-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lomond Therapeutics Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q4 2021 to Q1 2025.
- Lomond Therapeutics Holdings, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$705K, a 437% decline year-over-year.
- Lomond Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$12M, a 43.1% decline from 2023.
- Lomond Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$8.41M, a 18553% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)